These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10853924

  • 1. Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa.
    van West D, Monteleone P, Di Lieto A, De Meester I, Durinx C, Scharpe S, Lin A, Maj M, Maes M.
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(2):86-92. PubMed ID: 10853924
    [Abstract] [Full Text] [Related]

  • 2. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa.
    Maes M, Monteleone P, Bencivenga R, Goossens F, Maj M, van West D, Bosmans E, Scharpe S.
    Psychoneuroendocrinology; 2001 Jan; 26(1):17-26. PubMed ID: 11070331
    [Abstract] [Full Text] [Related]

  • 3. Eating disorders: a role for dipeptidyl peptidase IV in nutritional control.
    Hildebrandt M, Rose M, Mönnikes H, Reutter W, Keller W, Klapp BF.
    Nutrition; 2001 Jun; 17(6):451-4. PubMed ID: 11399402
    [Abstract] [Full Text] [Related]

  • 4. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders.
    Hildebrandt M, Rose M, Mayr C, Arck P, Schüler C, Reutter W, Salama A, Klapp BF.
    Adv Exp Med Biol; 2000 Jun; 477():197-204. PubMed ID: 10849747
    [Abstract] [Full Text] [Related]

  • 5. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders.
    Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, Klapp BF.
    Scand J Immunol; 1999 Nov; 50(5):536-41. PubMed ID: 10564557
    [Abstract] [Full Text] [Related]

  • 6. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease.
    Ferron F, Considine RV, Peino R, Lado IG, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):289-93. PubMed ID: 9156037
    [Abstract] [Full Text] [Related]

  • 7. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
    Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Meltzer H.
    Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
    [Abstract] [Full Text] [Related]

  • 8. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
    Maes M, Capuron L, Ravaud A, Gualde N, Bosmans E, Egyed B, Dantzer R, Neveu PJ.
    Neuropsychopharmacology; 2001 Feb; 24(2):130-40. PubMed ID: 11120395
    [Abstract] [Full Text] [Related]

  • 9. Comorbidity of anxiety disorders with anorexia and bulimia nervosa.
    Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K.
    Am J Psychiatry; 2004 Dec; 161(12):2215-21. PubMed ID: 15569892
    [Abstract] [Full Text] [Related]

  • 10. A study of temperament and personality in anorexia and bulimia nervosa.
    Díaz-Marsá M, Carrasco JL, Sáiz J.
    J Pers Disord; 2000 Dec; 14(4):352-9. PubMed ID: 11204342
    [Abstract] [Full Text] [Related]

  • 11. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
    Kaye WH, Berrettini W, Gwirtsman H, George DT.
    Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
    [Abstract] [Full Text] [Related]

  • 12. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers.
    Maes M, De Meester I, Verkerk R, De Medts P, Wauters A, Vanhoof G, Vandoolaeghe E, Neels H, Scharpé S.
    Psychoneuroendocrinology; 1997 Feb; 22(2):65-78. PubMed ID: 9149329
    [Abstract] [Full Text] [Related]

  • 13. Lifetime substance abuse, family history of alcohol abuse/dependence and novelty seeking in eating disorders: comparison study of eating disorder subgroups.
    Krug I, Pinheiro AP, Bulik C, Jiménez-Murcia S, Granero R, Penelo E, Masuet C, Agüera Z, Fernández-Aranda F.
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):82-7. PubMed ID: 19154214
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa.
    Monteleone P, Luisi M, Colurcio B, Casarosa E, Monteleone P, Ioime R, Genazzani AR, Maj M.
    Psychosom Med; 2001 Feb; 63(1):62-8. PubMed ID: 11211066
    [Abstract] [Full Text] [Related]

  • 15. Symptom fluctuation in eating disorders: correlates of diagnostic crossover.
    Tozzi F, Thornton LM, Klump KL, Fichter MM, Halmi KA, Kaplan AS, Strober M, Woodside DB, Crow S, Mitchell J, Rotondo A, Mauri M, Cassano G, Keel P, Plotnicov KH, Pollice C, Lilenfeld LR, Berrettini WH, Bulik CM, Kaye WH.
    Am J Psychiatry; 2005 Apr; 162(4):732-40. PubMed ID: 15800146
    [Abstract] [Full Text] [Related]

  • 16. Obsessive-compulsive disorder among patients with anorexia nervosa and bulimia nervosa.
    Thiel A, Broocks A, Ohlmeier M, Jacoby GE, Schüssler G.
    Am J Psychiatry; 1995 Jan; 152(1):72-5. PubMed ID: 7802124
    [Abstract] [Full Text] [Related]

  • 17. Thirty-month outcome in patients with anorexia or bulimia nervosa and concomitant obsessive-compulsive disorder.
    Thiel A, Züger M, Jacoby GE, Schüssler G.
    Am J Psychiatry; 1998 Feb; 155(2):244-9. PubMed ID: 9464205
    [Abstract] [Full Text] [Related]

  • 18. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa.
    Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V.
    Neuropsychopharmacology; 2005 Jun; 30(6):1216-21. PubMed ID: 15841111
    [Abstract] [Full Text] [Related]

  • 19. The significance of a prior history of anorexia in bulimia nervosa.
    Sullivan PF, Bulik CM, Carter FA, Gendall KA, Joyce PR.
    Int J Eat Disord; 1996 Nov; 20(3):253-61. PubMed ID: 8912037
    [Abstract] [Full Text] [Related]

  • 20. Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables.
    Monteleone P, Fabrazzo M, Martiadis V, Serritella C, Pannuto M, Maj M.
    Psychol Med; 2005 Jun; 35(6):897-905. PubMed ID: 15997610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.